1Berger J, Hinglais N . lntercapillary deposits of IgA IgG[J]. J Urol Nephrol, 1968,74 : 694.
2Monteiro RC, Halbwachs ML, Roque-Barreira MC et al. Charge and size of mesangial IgA in IgA nephropathy[J]. Kidney Int, 1985,28,666.
3Suzuki Y ,Matsuzaki K, SuzukiSerum H, et al. Lete:s of immuno- globulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy[J]. Cliri Exp Nephrol, 2014, 18:770.
4He LY, Liu H ,Peng YM. Immune pathogenesis of IgA nephropa- thy and its durgahle targets[J]. J Cent South Univ(Med Sci), 2014,39(1) :96.
5Robert T,Berthelot L, Cambier A, et al. Molecular Insights into the Pathogenesis of IgA Nephropathy[J]. Trends Mol Med,2015,21(12) :762.
6Xu LX, Ye ZM, Feng Z, et al. N-acetylgalactosamine exposure of serum IgA1 was associated with glomerulosclerosis and tubular atrophy fibrosis of IgA nephropathy patients[J]. Nephrology, 2014,19:32.
7Yamada K,Kobayashi N,Ikeda T,et al. Down-regulation of core 1 betal, 3- galactosyltransferase and Cosmc by Th2 cytokine alters O-gly-cosylation of IgA1 [J]. Nephrol Dial Transplant, 2010,25 (12) :3890.
8Stuchlova Horynova M, Vrablikova A, Stewart TJ, et al. N-Acetyiga- lactosaminide/2,6-sialyltransferase Ⅱ is a candidate enzyme for sialy- lation of galactose-de{icient IgA1, the key autoantigen in IgA nephro- pa-thy[J]. Nephrol Dial Transplant, 2015,30 : 234.
9Malycha F, Eggermann T, Hristov M. No evidence for a role of cosmc-chaperone mutations in European IgA nephropathy par- tients[J]. Nephrol Dial Transplant, 2009,24 : 321.
3Barratt J, Feehally J. IgA nephropathy. J Am Soc Nephrol, 2005,16:2088-2097.
4Allen AC, Topham PS, Harper SJ, et al. Leucocyte beta 1,3 galactosyhransferase activity in IgA nephropathy. Nephrol Dial Transplant, 1997,12:701-706.
5Qin w, Zhou Q, Yang LC, et al. Peripheral B lymphocyte beta1, 3-galactosyhransferase and chaperone expression in immunoglobulin A nephropathy. J Intern Med, 2005,258: 467-477.
6Pfaffl MW. A mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res, 2001,29:e45.
7Xu LX, Zhao MH. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. Kidney Int, 2005, 68:167-172.
8Ju T, Cummings RD. A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3- galactosyhransferase. Proc Natl Acad Sci USA, 2002,99: 16613-16618.
9Ju T, Cummings RD. Protein glycosylation: chaperone mutation in Tn syndrome. Nature, 2005,437(7063):1252.
10Suzuki S, Fujieda S, Sunaga H, et al. Synthesis of immunoglobulins against haemophilus parainfluenzae by tonsillar lymphocytes from patients with IgA nephropathy. Nephrol Dial Transplant, 2000,15:619-624.
